ProForma 2.0
validated simple linear
LKLKSIVSWAKKVL
Record tools
Copy identifiers or export this single peptide record for a local research note.
Mastoparan B
85
Quality PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness.
7
Source DBs
85
Activities
25
Source refs
9
Literature
1
Patents
Integrated record
Length
Molecular weight
Formula
Structure type
Synthesis
Chirality
Family
Gene
Residue composition
Physicochemical profile
Membrane affinity proxy
Solubility proxy
Net charge proxy +4
Binding interaction proxy
Versioned scientific descriptors
Legacy compatibility fields are materialized from the versioned PepDiana computed release; no separate source-reported property is available.
Molecular weight
1613.0393 Da
Molecular formula
C78H137N19O17
Theoretical pI
10.4777
Net charge at pH 7
3.7561
GRAVY
0.5714
Instability index
-31.7714
Aromaticity
0.0714
Topological polar surface area
601.95 Ų
cLogP
-1.5584
Hydrogen-bond donors
22
Hydrogen-bond acceptors
21
Rotatable bonds
57
Method: PepDiana sequence/structure descriptor pipeline
Tool: Biopython+RDKit · Biopython 1.85; RDKit 2024.09.6
Calculated: 2026-06-20T11:01:38.358971+00:00
Assumptions: ph=7; termini=free N-terminus and free C-terminus for simple linear peptides; stereochemistry=standard L-amino acids; smiles_length_limit=200
ProForma 2.0
validated simple linear
LKLKSIVSWAKKVL
HELM 2.0
validated simple linear
PEPTIDE1{L.K.L.K.S.I.V.S.W.A.K.K.V.L}$$$$V2.0
Canonical SMILES
validated
CCC(C)C(NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(N)CC(C)C)C(=O)NC(C(=O)NC(CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(=O)O)C(C)C)C(C)C
Isomeric SMILES
validated
CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
Follow-up research
Links open third-party resources with the current PepDiana sequence, record name, or chemistry notation as the initial query.
Research workflow
@misc{PEPDIA-INT-046405,
title = {Mastoparan B},
author = {{PepDiana Consortium}},
year = {2026},
howpublished = {PepDiana Multifunctional Peptide Database},
url = {http://127.0.0.1:3004/peptides/PEPDIA-INT-046405},
note = {Accessed from local PepDiana development build}
}Mastoparan B. (2026). PepDiana record PEPDIA-INT-046405. PepDiana Multifunctional Peptide Database. http://127.0.0.1:3004/peptides/PEPDIA-INT-046405
Integrated source-database annotations
| Stable record | Activity | Subtype | Value | Target | Assay method | Source |
|---|---|---|---|---|---|---|
| CTPDB_P046405_ACT_apd_0000 | Antimicrobial | Anti-Gram+ | Not available in the current structured import | Unknown | Not reported by source | AP00200apd / linked |
| CTPDB_P046405_ACT_apd_0001 | Anticancer | - | Not available in the current structured import | Unknown | Not reported by source | AP00200apd / linked |
| CTPDB_P046405_ACT_camp_0002 | Antimicrobial | Antibacterial | Not available in the current structured import | Unknown | Not reported by source | CAMPSQ2743camp / linked |
| CTPDB_P046405_ACT_camp_0003 | Antimicrobial | Anti-Gram- | Not available in the current structured import | Unknown | Not reported by source | CAMPSQ2743camp / linked |
| CTPDB_P046405_ACT_cancerppd_0004 | Anticancer | Anticancer | Not available in the current structured import | Unknown | Not Available | 4451cancerppd / linked |
| CTPDB_P046405_ACT_cancerppd_0005 | Antimicrobial | - | Not available in the current structured import | Unknown | Not Available | 4451cancerppd / linked |
| CTPDB_P046405_ACT_dbaasp_0006 | Antimicrobial | - | 5 µg/ml | Staphylococcus aureus ATCC 12600 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0007 | Antimicrobial | - | 50 µg/ml | Escherichia coli ATCC 11775 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0008 | Antimicrobial | - | 25 µg/ml | Candida albicans ATCC 10231 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0009 | Antimicrobial | - | 8 µg/ml | Botrytis cinerea | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0010 | Antimicrobial | - | 3.13 µg/ml | Enterococcus faecalis LS-101 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0011 | Antimicrobial | - | 12.5 µg/ml | Staphylococcus aureus FDA 209P | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0012 | Antimicrobial | - | >25 µg/ml | Staphylococcus aureus 1840 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0013 | Antimicrobial | - | 6.25 µg/ml | Staphylococcus epidermidis ATCC 12228 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0014 | Antimicrobial | - | 3.13 µg/ml | Bacillus subtilis PCI 219 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0015 | Antimicrobial | - | 12.5 µg/ml | Escherichia coli NIHJ JC-2 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0016 | Antimicrobial | - | 6.25 µg/ml | Shigella flexneri EW-10 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0017 | Antimicrobial | - | 6.25 µg/ml | Shigella sonnei EW-33 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0018 | Antimicrobial | - | >25 µg/ml | Klebsiella pneumoniae | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0019 | Antimicrobial | - | 12.5 µM | Enterococcus faecium EFMY-28 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0020 | Antimicrobial | - | 8.0±6.9 µg/ml | Pseudomonas aeruginosa | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0021 | Antimicrobial | - | 8.0±6.9 µg/ml | Pseudomonas aeruginosa | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0022 | Antimicrobial | - | 1.7±0.6 µg/ml | Acinetobacter baumannii | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0023 | Antimicrobial | - | 2.0±0.0 µg/ml | Acinetobacter baumannii | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0024 | Antimicrobial | - | 13.3±4.6 µg/ml | Staphylococcus aureus | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0025 | Antimicrobial | - | 16.0±0.0 µg/ml | Staphylococcus aureus | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0026 | Antimicrobial | - | 10.7±4.6 µg/ml | Enterococcus faecalis | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0027 | Antimicrobial | - | 10.7±4.6 µg/ml | Enterococcus faecalis | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0028 | Antimicrobial | - | 16 µg/ml | Pseudomonas aeruginosa ATCC 27853 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0029 | Antimicrobial | - | 64 µg/ml | Pseudomonas aeruginosa ATCC 27853 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0030 | Antimicrobial | - | 64 µg/ml | Pseudomonas aeruginosa ATCC 27853 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0031 | Antimicrobial | - | 16 µg/ml | Pseudomonas aeruginosa ATCC 27853 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0032 | Antimicrobial | - | 4-8 µg/ml | Escherichia coli BL21 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0033 | Antimicrobial | - | 4-8 µg/ml | Escherichia coli BL21 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0034 | Antimicrobial | - | 1 µg/ml | Escherichia coli JM109 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0035 | Antimicrobial | - | 2-4 µg/ml | Escherichia coli JM109 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0036 | Antimicrobial | - | 16-32 µg/ml | Staphylococcus aureus CCRC 15211 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0037 | Antimicrobial | - | 16-32 µg/ml | Staphylococcus aureus CCRC 15211 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0038 | Antimicrobial | - | 16 µg/ml | Staphylococcus aureus CCRC 12652 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0039 | Antimicrobial | - | 16-32 µg/ml | Staphylococcus aureus CCRC 12652 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0040 | Antimicrobial | - | 0.5 µg/ml | Staphylococcus xylosus | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0041 | Antimicrobial | - | 4-8 µg/ml | Staphylococcus xylosus | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0042 | Antimicrobial | - | 64 µg/ml | Klebsiella pneumoniae CCRC 10694 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0043 | Antimicrobial | - | 128 µg/ml | Klebsiella pneumoniae CCRC 10694 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0044 | Antimicrobial | - | 2-4 µg/ml | Citrobacter koseri | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0045 | Antimicrobial | - | 128 µg/ml | Citrobacter koseri | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0046 | Antimicrobial | - | 64 µg/ml | Pseudomonas aeruginosa | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0047 | Antimicrobial | - | 128 µg/ml | Pseudomonas aeruginosa | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0048 | Antimicrobial | - | 8-16 µg/ml | Vibrio parahaemolyticus CCRC 10806 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0049 | Antimicrobial | - | 32-64 µg/ml | Vibrio parahaemolyticus CCRC 10806 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0050 | Antimicrobial | - | 32 µg/ml | Salmonella typhimurium CCRC 12947 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0051 | Antimicrobial | - | 64-128 µg/ml | Salmonella typhimurium CCRC 12947 | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0052 | Antimicrobial | - | 32 µg/ml | Salmonella enterica | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0053 | Antimicrobial | - | 64 µg/ml | Salmonella enterica | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0054 | Antimicrobial | - | 128 µg/ml | Bifidobacterium adolescentis | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0055 | Antimicrobial | - | 128 µg/ml | Lactobacillus delbrueckii subsp. bulgaricus | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dbaasp_0056 | Antimicrobial | - | 128 µg/ml | Enterococcus faecium | Not reported by source | DBAASPS_3329_chain0dbaasp / linked |
| CTPDB_P046405_ACT_dramp_0057 | Antimicrobial | - | Not available in the current structured import | Unknown | Not reported by source | DRAMP03024dramp / linked |
| CTPDB_P046405_ACT_dramp_0058 | Antimicrobial | Antibacterial | Not available in the current structured import | Unknown | Not reported by source | DRAMP03024dramp / linked |
| CTPDB_P046405_ACT_dramp_0059 | Antimicrobial | Anti-Gram+ | Not available in the current structured import | Unknown | Not reported by source | DRAMP03024dramp / linked |
| CTPDB_P046405_ACT_dramp_0060 | Antimicrobial | Anti-Gram- | Not available in the current structured import | Unknown | Not reported by source | DRAMP03024dramp / linked |
| CTPDB_P046405_ACT_dramp_0061 | Unknown | Anti Mammalian cells | Not available in the current structured import | Unknown | Not reported by source | DRAMP03024dramp / linked |
| CTPDB_P046405_ACT_dramp_0062 | Anticancer | - | Not available in the current structured import | Unknown | Not reported by source | DRAMP03024dramp / linked |
| CTPDB_P046405_ACT_dramp_0063 | Antimicrobial | - | Not available in the current structured import | Unknown | Not reported by source | DRAMP28543dramp / linked |
| CTPDB_P046405_ACT_hemolytik_0066 | Toxicity | Hemolytic | 15.0 µM | Erythrocytes | Not reported by source | 1973hemolytik / linked |
| CTPDB_P046405_ACT_hemolytik_0067 | Toxicity | Hemolytic | 20.0 µM | Erythrocytes | Not reported by source | 1974hemolytik / linked |
| CTPDB_P046405_ACT_hemolytik_0068 | Toxicity | Hemolytic | 15.0 µM | Erythrocytes | Not reported by source | 1975hemolytik / linked |
| CTPDB_P046405_ACT_hemolytik_0069 | Toxicity | Hemolytic | 20.0 µM | Erythrocytes | Not reported by source | 1976hemolytik / linked |
| CTPDB_P046405_ACT_hemolytik_0070 | Toxicity | Hemolytic | 15.0 µM | Erythrocytes | Not reported by source | 1977hemolytik / linked |
| CTPDB_P046405_ACT_hemolytik_0071 | Toxicity | Hemolytic | 20.0 µM | Erythrocytes | Not reported by source | 1978hemolytik / linked |
| CTPDB_P046405_ACT_hemolytik_0072 | Toxicity | Hemolytic | 15.0 µM | Erythrocytes | Not reported by source | 1979hemolytik / linked |
| CTPDB_P046405_ACT_hemolytik_0073 | Toxicity | Hemolytic | 20.0 µM | Erythrocytes | Not reported by source | 1980hemolytik / linked |
| CTPDB_P046405_ACT_hemolytik_0074 | Toxicity | Hemolytic | 15.0 µM | Erythrocytes | Not reported by source | 1981hemolytik / linked |
| CTPDB_P046405_ACT_hemolytik_0075 | Toxicity | Hemolytic | 20.0 µM | Erythrocytes | Not reported by source | 1982hemolytik / linked |
| CTPDB_P046405_ACT_hemolytik_0076 | Toxicity | Hemolytic | Not available in the current structured import | Erythrocytes | Not reported by source | 2000hemolytik / linked |
| CTPDB_P046405_ACT_hemolytik_0064 | Toxicity | Hemolytic | 30.0 µM | Erythrocytes | Not reported by source | 3497hemolytik / linked |
| CTPDB_P046405_ACT_hemolytik_0065 | Toxicity | Hemolytic | 20.0 µM | Erythrocytes | Not reported by source | 3498hemolytik / linked |
| CTPDB_P046405_ACT_satpdb_0077 | Toxicity | General Toxic | Not available in the current structured import | Unknown | Not reported by source | satpdb10111satpdb / linked |
| CTPDB_P046405_ACT_satpdb_0078 | Antimicrobial | - | Not available in the current structured import | Unknown | Not reported by source | satpdb10111satpdb / linked |
| CTPDB_P046405_ACT_satpdb_0079 | Toxicity | General Toxic | Not available in the current structured import | Unknown | Not reported by source | satpdb10675satpdb / linked |
| CTPDB_P046405_ACT_satpdb_0080 | Toxicity | General Toxic | Not available in the current structured import | Unknown | Not reported by source | satpdb16799satpdb / linked |
| CTPDB_P046405_ACT_satpdb_0081 | Anticancer | - | Not available in the current structured import | Unknown | Not reported by source | satpdb19410satpdb / linked |
| CTPDB_P046405_ACT_satpdb_0082 | Antimicrobial | - | Not available in the current structured import | Unknown | Not reported by source | satpdb19410satpdb / linked |
| CTPDB_P046405_ACT_satpdb_0083 | Toxicity | General Toxic | Not available in the current structured import | Unknown | Not reported by source | satpdb26831satpdb / linked |
| CTPDB_P046405_ACT_satpdb_0084 | Toxicity | General Toxic | Not available in the current structured import | Unknown | Not reported by source | satpdb27033satpdb / linked |
Sequence-linked cross-layer evidence
2
Records
1
Papers
0
Positive
2
Negative
1
Primary identities
These observations were collected directly from primary literature and linked by identical normalized sequence. They remain a separate evidence layer and do not overwrite Integrated source-database annotations.
Provenance
LKLKSIVSWAKKVL
LKLKSIVSWAKKVL
LKLKSIVSWAKKVL
LKLKSIVSWAKKVL
LKLKSIVSWAKKVL
LKLKSIVSWAKKVL
LKLKSIVSWAKKVL
LKLKSIVSWAKKVL
LKLKSIVSWAKKVL
LKLKSIVSWAKKVL
lklksivswakkvl
lklksivswakkvl
LkLKSIVSWAKKVL
LkLKSIVSWAKKVL
LKLkSIVSWAKKVL
LKLkSIVSWAKKVL
LKLKSIVSWAkkVL
LKLKSIVSWAkkVL
LKLKSIVSWAKKVL
LKLKSIVSWAKKVL
LkLKSIVSWAKKVL
LKLKSIVSWAkkVL
LKLKSIVSWAKKVL
lklksivswakkvl
LKLkSIVSWAKKVL
Citation trail
{"reference": "Biopolymers. 1995 Dec;36(6):793-801", "title": "Interaction of mastoparan-B from venom of a hornet in Taiwan with phospholipid bilayers and its antimicrobial activity", "author": "Park NG, Yamato Y, Lee S, Sugihara G1995"}
-
-
Baek JH, Lee SH
Baek JH, Lee SH
Baek JH, Lee SH
Baek JH, Lee SH
-
-
IP evidence
US 20190276505
dramp
Audit surface
Integrated record last updated: 2026-04-15T00:59:11.941613+00:00
Modification summary
No structured modification annotations are available for this record.
{
"toxicity": [
{
"unit": "µM",
"value": "50",
"source_db": "dbaasp",
"assay_method": "38% Hemolysis",
"toxicity_type": "Hemolytic",
"target_cellline": "Human erythrocytes"
},
{
"unit": "µM",
"value": "100",
"source_db": "dbaasp",
"assay_method": "68% Hemolysis",
"toxicity_type": "Hemolytic",
"target_cellline": "Human erythrocytes"
},
{
"unit": "µM",
"value": "15",
"source_db": "dbaasp",
"assay_method": "41% Hemolysis",
"toxicity_type": "Hemolytic",
"target_cellline": "Guinea pig erythrocytes"
},
{
"unit": "µM",
"value": "20",
"source_db": "dbaasp",
"assay_method": "81% Hemolysis",
"toxicity_type": "Hemolytic",
"target_cellline": "Guinea pig erythrocytes"
},
{
"unit": "µM",
"value": "30",
"source_db": "dbaasp",
"assay_method": "96% Hemolysis",
"toxicity_type": "Hemolytic",
"target_cellline": "Guinea pig erythrocytes"
},
{
"unit": "µg/ml",
"value": "128",
"source_db": "dbaasp",
"assay_method": "5% Hemolysis",
"toxicity_type": "Hemolytic",
"target_cellline": "Human erythrocytes"
},
{
"unit": "µg/ml",
"value": "64",
"source_db": "dbaasp",
"assay_method": "0% Hemolysis",
"toxicity_type": "Hemolytic",
"target_cellline": "Sheep erythrocytes"
},
{
"unit": "µg/ml",
"value": "32",
"source_db": "dbaasp",
"assay_method": "50% Cell death",
"toxicity_type": "Cytotoxic",
"target_cellline": "Human embryonic kidney HEK293 cells"
},
{
"source_db": "dbaasp",
"assay_method": "-",
"toxicity_type": "Hemolytic",
"target_cellline": "Goat erythrocytes"
},
{
"source_db": "dbaasp",
"assay_method": "-",
"toxicity_type": "Hemolytic",
"target_cellline": "Chicken erythrocytes"
},
{
"unit": "µM",
"source_db": "dramp",
"assay_method": "[Ref.10667861] 68.2% hemolysis at the peptide concentration of 100 µM is , 27.9% Hemolysis at 50 µM against human red blood cells.",
"toxicity_type": "Hemolytic",
"target_cellline": "Erythrocytes"
},
{
"unit": "µM",
"source_db": "dramp",
"assay_method": "[Ref.10667861]No cytotoxicity information found##[Ref.8555423]No cytotoxicity information found",
"toxicity_type": "Cytotoxic"
}
]
}[
{
"source_db": "apd",
"organism_name": "Unknown"
},
{
"source_db": "camp",
"organism_name": "Unknown"
},
{
"source_db": "cancerppd",
"organism_name": "Unknown"
},
{
"source_db": "dbaasp",
"organism_name": "Unknown"
},
{
"source_db": "dramp",
"organism_name": "Unknown"
},
{
"source_db": "hemolytik",
"organism_name": "Unknown"
},
{
"source_db": "satpdb",
"organism_name": "Unknown"
}
]{
"source_db": "satpdb",
"dssp_states": "CCCSTTHHHHHHHC"
}